Synopsys (NASDAQ:SNPS) Now Covered by Redburn Atlantic

Redburn Atlantic began coverage on shares of Synopsys (NASDAQ:SNPSFree Report) in a research report report published on Monday, Marketbeat reports. The brokerage issued a buy rating and a $600.00 price objective on the semiconductor company’s stock.

SNPS has been the subject of a number of other research reports. Wells Fargo & Company started coverage on Synopsys in a research report on Friday, November 22nd. They set an “equal weight” rating and a $570.00 price objective for the company. Needham & Company LLC reissued a “buy” rating and set a $640.00 price objective on shares of Synopsys in a research report on Thursday, December 5th. Rosenblatt Securities reissued a “buy” rating and set a $635.00 price objective on shares of Synopsys in a research report on Wednesday, December 4th. Loop Capital started coverage on Synopsys in a research report on Monday, November 11th. They set a “buy” rating and a $675.00 price objective for the company. Finally, Piper Sandler reduced their price objective on Synopsys from $670.00 to $655.00 and set an “overweight” rating for the company in a research report on Friday, December 6th. One investment analyst has rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $641.82.

Check Out Our Latest Stock Report on Synopsys

Synopsys Trading Down 1.0 %

SNPS opened at $487.43 on Monday. The stock has a market cap of $75.35 billion, a price-to-earnings ratio of 33.57, a PEG ratio of 3.41 and a beta of 1.12. Synopsys has a 1 year low of $457.52 and a 1 year high of $629.38. The stock has a fifty day moving average price of $522.84 and a 200 day moving average price of $528.17.

Hedge Funds Weigh In On Synopsys

A number of institutional investors have recently made changes to their positions in the business. Hazlett Burt & Watson Inc. increased its stake in shares of Synopsys by 40.0% in the third quarter. Hazlett Burt & Watson Inc. now owns 70 shares of the semiconductor company’s stock worth $35,000 after purchasing an additional 20 shares during the period. Green Alpha Advisors LLC increased its stake in shares of Synopsys by 1.7% in the third quarter. Green Alpha Advisors LLC now owns 1,294 shares of the semiconductor company’s stock worth $655,000 after purchasing an additional 22 shares during the period. Aptus Capital Advisors LLC increased its stake in shares of Synopsys by 1.5% in the third quarter. Aptus Capital Advisors LLC now owns 1,447 shares of the semiconductor company’s stock worth $733,000 after purchasing an additional 22 shares during the period. Resurgent Financial Advisors LLC increased its stake in shares of Synopsys by 2.8% in the third quarter. Resurgent Financial Advisors LLC now owns 809 shares of the semiconductor company’s stock worth $410,000 after purchasing an additional 22 shares during the period. Finally, Larson Financial Group LLC increased its stake in shares of Synopsys by 6.1% in the third quarter. Larson Financial Group LLC now owns 398 shares of the semiconductor company’s stock worth $202,000 after purchasing an additional 23 shares during the period. 85.47% of the stock is currently owned by institutional investors.

About Synopsys

(Get Free Report)

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.

Further Reading

Analyst Recommendations for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.